London, England: 1993), pp. 815-818.
2. Zangen, A., et al., Furosemide and digoxin inhibit
thiamine uptake in cardiac cells. Eur. J.
Pharmacol., 361(1), 151-155 (1998).
3. Gutschmidt, K. U., et al
V. et al, Stem Cells, 11, 150-155 (1993).
Giddings, J.C. et al., Clin. Lab. Hematol., 2, 121-128
(1980).
Monocytes
Przepiorka, D et al., Am. J. Clin. Pathol., 95, 201-206
(1991).
Osipovich, O.A. et al
V. et al, Stem Cells, 11, 150-155 (1993).
Giddings, J.C. et al., Clin. Lab. Hematol., 2, 121-128
(1980).
Monocytes
Przepiorka, D et al., Am. J. Clin. Pathol., 95, 201-206
(1991).
Osipovich, O.A. et al
V. et al, Stem Cells, 11, 150-155 (1993).
Giddings, J.C. et al., Clin. Lab. Hematol., 2, 121-128
(1980).
Monocytes
Przepiorka, D et al., Am. J. Clin. Pathol., 95, 201-206
(1991).
Osipovich, O.A. et al
V. et al, Stem Cells, 11, 150-155 (1993).
Giddings, J.C. et al., Clin. Lab. Hematol., 2, 121-128
(1980).
Monocytes
Przepiorka, D et al., Am. J. Clin. Pathol., 95, 201-206
(1991).
Osipovich, O.A. et al
Clone:PKB-175 P2482 Signal Transduction M y y y
205 PKB/AKT P1601 Signal Transduction P y y y
206 PKB phosphoserine 473 (pS
473) P4112 Signal Transduction P n/d y y
207 PKB phosphothreonine 308
predictive nomogram. ACLF Grade 1 was seen in 11 patients
(4.7%), Grade 2 in 11 patients (4.7%), Grade 3 in 7 patients (3.0%) and
206 patients (87.7%) were identified as ACLF Grade 0 during hospita-
lization
Mater. Chem. A 2015, 3 (43), 21922–21929.
(15) Hu, L., et al. Sol. Energy Mater. Sol. Cells 2016, 155, 155–165.
(16) Lu, K., et al. J. Mater. Chem. A 2017, 5 (45), 23960–23966.
(17) Zhang, J., et al. Nano
C5176 M y n/d n/d
204 Cytokeratin CK5 C7785 M y n/d n/d
205 Cytokeratin peptide 7 C6417 M y n/d n/d
206 Cytokeratin 8.12 C7034 M y n/d n/d
207 Cytokeratin 8.13 C6909 M y n/d n/d
208 Cytokeratin peptide 13
3875 KRT18 NP_954657.1 M y n/d n/d
205 Cytokeratin peptide 7 C6417 3855 KRT7 NP_005547.3 M y n/d n/d
206 Cytokeratin 8.12 C7034 3866, 3860, 3868 KRT15,KRT16,KRT13 NP_002266.2,NP_705694.2,NP_005548.2 M y n
3875 KRT18 NP_954657.1 M y n/d n/d
205 Cytokeratin peptide 7 C6417 3855 KRT7 NP_005547.3 M y n/d n/d
206 Cytokeratin 8.12 C7034 3866, 3860, 3868 KRT15,KRT16,KRT13 NP_002266.2,NP_705694.2,NP_005548.2 M y n